English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 328 Help

  Show only claimed items
Selected(0)Clear Items/Page:    Sort:
Corrigendum to “Comprehensive comparison on the anti-inflammatory effects of three species of Sigesbeckia plants based on NF-κB and MAPKs signal pathways in vitro” [J. Ethnopharmacol. 250, 25 March (2020), 112530] (Journal of Ethnopharmacology (2020) 250, (S0378874119320197), (10.1016/j.jep.2019.112530)) Other
2025-01-31
Authors:  Linghu, Ke Gang;  Zhao, Guan Ding;  Xiong, Wei;  Sang, Wei;  Xiong, Shi Hang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2025/01/22
Pre-Ligand Assembly Domain-Derived Recombinant Proteins of TNFR2 Inhibits the Expansion of CD4+Foxp3+ Regulatory T Cells Journal article
WEN-WEI LI, CHUANGEN LI, YANG YANG, YIBO CHEN; Yexuan Zhang; Hong Cai; Chon Kit CHOU; Xin Chen; Yuanjia Hu*, ZHONGHAO CHEN, YANG GAO, YIRU WANG, XIN CHEN, Chon-Kit Chou. Pre-Ligand Assembly Domain-Derived Recombinant Proteins of TNFR2 Inhibits the Expansion of CD4+Foxp3+ Regulatory T Cells[J]. Journal of Leukocyte Biology, 2025.
Authors:  WEN-WEI LI;  CHUANGEN LI;  YANG YANG;  YIBO CHEN;   Yexuan Zhang;   Hong Cai;   Chon Kit CHOU;   Xin Chen;   Yuanjia Hu*;  ZHONGHAO CHEN; et al.
Favorite |   IF:3.6/5.2 | Submit date：2025/01/17
Profiling patent compounds in lipid nanoparticle formulations of siRNA Journal article
Han, Yunfeng, Wang, Mengyang, Chen, Yu, Ouyang, Defang, Zheng, Ying, Hu, Yuanjia. Profiling patent compounds in lipid nanoparticle formulations of siRNA[J]. Molecular Therapy Nucleic Acids, 2024, 35(4), 102362.
Authors:  Han, Yunfeng;  Wang, Mengyang;  Chen, Yu;  Ouyang, Defang;  Zheng, Ying; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:6.5/6.7 | Submit date：2024/12/05
Factors affecting community pharmacists' capacity to deliver pharmacy services in Zhengzhou, China: a cross-sectional study Journal article
Meng, Wenxin, Wang, Yanan, Shen, Jian, Yan, Mingxun, Hu, Yuanjia, Jiang, Rong. Factors affecting community pharmacists' capacity to deliver pharmacy services in Zhengzhou, China: a cross-sectional study[J]. BMJ OPEN, 2024, 14(10), e083104.
Authors:  Meng, Wenxin;  Wang, Yanan;  Shen, Jian;  Yan, Mingxun;  Hu, Yuanjia; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.4/2.7 | Submit date：2024/12/05
Capacity Building  China  Factor Analysis, Statistical  Health Services  Pharmacists  
Ganweikang extract protects hepatocytes from oxidative injury by activating Nrf2/HO-1 and MAPKs pathways Journal article
Xiao Linxuan, Zhao Mingming, Linghu Ke-Gang, Wu Guoping, Zhang Tian, Chen Chengyu, Guan Jianli, Cao Zhiming, HU YUANJIA, Yu Hua. Ganweikang extract protects hepatocytes from oxidative injury by activating Nrf2/HO-1 and MAPKs pathways[J]. Fitoterapia, 2024, 178, 106146.
Authors:  Xiao Linxuan;  Zhao Mingming;  Linghu Ke-Gang;  Wu Guoping;  Zhang Tian; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.5/2.7 | Submit date：2024/08/29
Ganweikang  Acute Hepatic Injury  Hepato-protection  Nrf2/ho-1  Mapks  
Exploring the mechanisms of Yuanhu Zhitong oral liquid for primary dysmenorrhea through network pharmacology, molecular docking, and molecular dynamics simulation Journal article
Zhang, Cheng Rui, Zhang, Dai Yan, Gao, Jin, Cao, Zhi Ming, Hu, Yuan Jia. Exploring the mechanisms of Yuanhu Zhitong oral liquid for primary dysmenorrhea through network pharmacology, molecular docking, and molecular dynamics simulation[J]. Reproductive and Developmental Medicine, 2024, 8(3), 138-150.
Authors:  Zhang, Cheng Rui;  Zhang, Dai Yan;  Gao, Jin;  Cao, Zhi Ming;  Hu, Yuan Jia
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:0.7/0.6 | Submit date：2024/10/10
Molecular Docking  Network Pharmacology  Primary Dysmenorrhea  Yuanhu Zhitong Oral Liquid  
Big Data Analysis of Patents and Their Applications in Biomedical Research and Development Book chapter
出自: Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0:wiley, 2024, 页码:533-573
Authors:  Xu Jiaqi;  Yuan Jialu;  Cai hong;  HU YUANJIA
Favorite | TC[Scopus]:0 | Submit date：2024/08/29
BioInformatics In Patents  Biomedical Research  ChemInformatics In Patents  Data Mining  Patent Analysis  Pharmaceutics Patents  
Mapping the global landscape for induced pluripotent stem cells from patents and clinical trials Journal article
Lyu, Liyang, Feng, Ye, Huang, Borong, Xu, Ren He, Hu, Yuanjia. Mapping the global landscape for induced pluripotent stem cells from patents and clinical trials[J]. Nature Biotechnology, 2024, 42(4), 563-569.
Authors:  Lyu, Liyang;  Feng, Ye;  Huang, Borong;  Xu, Ren He;  Hu, Yuanjia
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:33.1/56.9 | Submit date：2024/05/02
Small molecule deoxynyboquinone triggers alkylation and ubiquitination of Keap1 at Cys489 on Kelch domain for Nrf2 activation and inflammatory therapy Journal article
Linghu, Ke-Gang, Zhang, Tian, Zhang, Guang-Tao, Lv, Peng, Zhang, Wenjun, Zhao, Guanding, Xiong, Shihong, Zhao, Mingming, Chen, Meiwan, HU YUANJIA, Zhang, Changsheng, Yu, Hua. Small molecule deoxynyboquinone triggers alkylation and ubiquitination of Keap1 at Cys489 on Kelch domain for Nrf2 activation and inflammatory therapy[J]. Journal of Pharmaceutical Analysis, 2024, 14(3), 401-415.
Authors:  Linghu, Ke-Gang;  Zhang, Tian;  Zhang, Guang-Tao;  Lv, Peng;  Zhang, Wenjun; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9  IF:6.1/6.8 | Submit date：2024/01/02
Deoxynyboquinone  Anti-inflammation  Target  Keap1/nrf2  Alkylation  Ubiquitination  
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:6.1/6.7 | Submit date：2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors